These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12974392)

  • 1. Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase.
    Loak K; Li DN; Manoury B; Billson J; Morton F; Hewitt E; Watts C
    Biol Chem; 2003 Aug; 384(8):1239-46. PubMed ID: 12974392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
    Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
    Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of legumain.
    Schwarz G; Brandenburg J; Reich M; Burster T; Driessen C; Kalbacher H
    Biol Chem; 2002 Nov; 383(11):1813-6. PubMed ID: 12530547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cells.
    Reich M; Wieczerzak E; Jankowska E; Palesch D; Boehm BO; Burster T
    Immunol Lett; 2009 Apr; 123(2):155-9. PubMed ID: 19428564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.
    Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
    Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bm-CPI-2, a cystatin from Brugia malayi nematode parasites, differs from Caenorhabditis elegans cystatins in a specific site mediating inhibition of the antigen-processing enzyme AEP.
    Murray J; Manoury B; Balic A; Watts C; Maizels RM
    Mol Biochem Parasitol; 2005 Feb; 139(2):197-203. PubMed ID: 15664654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S.
    Thurmond RL; Beavers MP; Cai H; Meduna SP; Gustin DJ; Sun S; Almond HJ; Karlsson L; Edwards JP
    J Med Chem; 2004 Sep; 47(20):4799-801. PubMed ID: 15369380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
    James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
    Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytes.
    Wolk K; Grütz G; Witte K; Volk HD; Sabat R
    Genes Immun; 2005 Aug; 6(5):452-6. PubMed ID: 15875056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases.
    Ghittoni R; Napolitani G; Benati D; Ulivieri C; Patrussi L; Laghi Pasini F; Lanzavecchia A; Baldari CT
    Eur J Immunol; 2006 Nov; 36(11):2885-93. PubMed ID: 17048274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones.
    Niestroj AJ; Feussner K; Heiser U; Dando PM; Barrett A; Gerhartz B; Demuth HU
    Biol Chem; 2002; 383(7-8):1205-14. PubMed ID: 12437107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two novel asparaginyl endopeptidase-like cysteine proteinases from the protist Trichomonas vaginalis: their evolutionary relationship within the clan CD cysteine proteinases.
    León-Félix J; Ortega-López J; Orozco-Solís R; Arroyo R
    Gene; 2004 Jun; 335():25-35. PubMed ID: 15194187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asparaginyl endopeptidase: case history of a class II MHC compartment protease.
    Watts C; Matthews SP; Mazzeo D; Manoury B; Moss CX
    Immunol Rev; 2005 Oct; 207():218-28. PubMed ID: 16181339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain.
    Sexton KB; Witte MD; Blum G; Bogyo M
    Bioorg Med Chem Lett; 2007 Feb; 17(3):649-53. PubMed ID: 17189693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells.
    Burster T; Reich M; Zaidi N; Voelter W; Boehm BO; Kalbacher H
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1299-303. PubMed ID: 18996084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
    Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
    J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
    Pinard E; Alberati D; Borroni E; Fischer H; Hainzl D; Jolidon S; Moreau JL; Narquizian R; Nettekoven M; Norcross RD; Stalder H; Thomas AW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5134-9. PubMed ID: 18752953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.